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Abstract
Recently, reactive oxygen species (ROS) have been 
studied as a regulator of differentiation into specific 
cell types in embryonic stem cells (ESCs). However, 
ROS role in human ESCs (hESCs) is unknown because 
mouse ESCs have been used mainly for most studies. 
Herein we suggest that ROS generation may play a crit-
ical role in differentiation of hESCs; ROS enhances dif-
ferentiation of hESCs into bi-potent mesendodermal 
cell lineage via ROS-involved signaling pathways. In 
ROS-inducing conditions, expression of pluripotency 
markers (Oct4, Tra 1-60, Nanog, and Sox2) of hESCs 
was decreased, while expression of mesodermal and 
endodermal markers was increased. Moreover, these 
differentiation events of hESCs in ROS-inducing con-
ditions were decreased by free radical scavenger 
treatment. hESC-derived embryoid bodies (EBs) also 
showed similar differentiation patterns by ROS induc-
tion. In ROS-related signaling pathway, some of the 
MAPKs family members in hESCs were also affected 
by ROS induction. p38 MAPK and AKT (protein kinases 
B, PKB) were inactivated significantly by buthionine 
sulfoximine (BSO) treatment. JNK and ERK phosphor-
ylation levels were increased at early time of BSO treat-
ment but not at late time point. Moreover, MAPKs fam-
ily-specific inhibitors could prevent the mesen-
dodermal differentiation of hESCs by ROS induction. 
Our results demonstrate that stemness and differ-
entiation of hESCs can be regulated by environmental 
factors such as ROS.
Keywords: cell differentiation; embryonic stem cells; 
mitogen-activated protein kinases; reactive oxygen 
species
Introduction
Human embryonic stem cells (hESCs) have a 
common characteristic; hESCs are capable of 
generating identical daughter cells by unlimited cell 
divisions and differentiating into all cell types 
(Carpenter et al., 2004). This ability of hESCs has 
been shown to be dependent on the intrinsic 
regulators and the extracellular environment niche. 
Recent reports have suggested that various 
extracellular ligands bind to their specific cell 
surface receptors, and the ligand-receptor interac-
tions activate diverse intracellular signal transduc-
tions (Rhee, 1999). Activated intracellular signaling 
pathways are amplified by secondary messengers, 
thus managing the expression of transcription 
factors that induce cell responses, such as prolife-
ration, differentiation, and apoptosis (Sohal et al., 
1986). Recently, reactive oxygen species (ROS), 
which are free radicals, have been shown to be 
secondary messengers in cell signal transduction 
(Rhee, 1999). ROS generated at low-to-moderate 
concentrations act as signaling molecules that are 
involved in signal transduction-mediated biological 
effects in cells. Such effects of ROS are related to 
differences in the concentrations of ROS (Valko et 
al., 2007). 
    ROS are generated by signal transduction 
cascades of various growth factor-, cytokine-, and 
hormone-mediated pathways and then induce 
individual cellular responses in non-phagocytic 
cells (Thannickal and Fanburg, 2000). Moreover, 
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Figure 1. Generation of endogenous ROS in hESCs by buthionine sulfoximine (BSO), generated ROS was measured by staining with 2', 
7'dichlorofluorescene acetate (DCF-DA). (A) Endogenous ROS measurement. Treatment in vitro with BSO increased levels of intracellular ROS in a 
dose-dependent manner. Fluorescent DCF was monitored by FACS analysis. *P ＜ 0.05, significantly different from the untreated controls (n = 3). (B) 
Apoptosis analysis on response to elevated ROS levels in hESCs. Cells were cultured in DMEM/F12-containing BSO in a dose-dependent manner. BSO 
at a high concentration induced apoptosis of hESCs, which increased the number of dead and floating cells. Representative flow cytometry data are 
shown annexin V incorporation (FL1) and PI staining (FL2) (n = 3). *P ＜ 0.05, significantly different from the untreated controls.
various growth factors that bind to receptor 
tyrosine kinases (RTKs) have been reported to 
induce endogenous ROS. Shibanuma et al. (1990) 
reported that PDGF stimulates cellular production 
of H2O2, which is thought to be a competence 
factor in BALB/3T3 cell proliferation. PDGF also 
induces the signal transducer and activator of 
transcription (STAT) family via a H2O2-dependent 
mechanism (Simon et al., 1998). 
    Interestingly, recent studies on the effects of 
ROS in mouse ESCs (mESCs) have increased; 
ROS have been reported that it play a crucial role 
in cell differentiation to regulate mESCs (Sauer 
and Wartenberg, 2005; Valko et al., 2007). Pre-
vious studies have reported the function of ROS in 
mESCs differentiation into cardiomyocytes; ROS 
promotes differentiation toward both cardiomyo-
genic and vascular cell lineages in mESCs (Sauer 
and Wartenberg, 2005). In mESCs, increasing evi-
dence implies that cardiomyogenesis is directly 
influenced by ROS through the MAPKs family 
(Sauer and Wartenberg, 2005). The ROS-activated 
MAPKs family consists of ERK 1/2, JNK and p38 
MAPK, which play a crucial role in cell differen-
tiation and have been reported to regulate ESCs 
(Sauer and Wartenberg, 2005; Valko et al., 2007). 
Hypoxia regulate the expression of cardiotrophin-1 
(CT-1), and hypoxia induced factor-1 (HIF-1) were 
increased during cardiomyogenesis of differentiating 
mESCs by the ROS-related MAPKs family 
(Ateghang et al., 2006). ROS-induced differentia-
tion was stimulated by a ROS-modulated signaling 
pathway in mESCs (Sauer et al., 2000; Sauer and 
Wartenberg, 2005; Ateghang et al., 2006). 
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Figure 1. Continued.
    To date, previous studies have identified the 
effects of ROS in mESC differentiation; ROS 
stimulate the differentiation of mESCs into specific 
lineages by a ROS-modulated signaling pathway 
(Sauer and Wartenberg, 2005; Ateghang et al., 
2006). However, the importance of ROS in the in 
vitro differentiation of hESCs into specific lineages 
has not been underestimated. In the current study, 
we investigated the changes in hESC pluripotency 
in a ROS-induced system. We demonstrated the 
diminished pluripotency of hESCs induced by 
continuous exposure to ROS. Moreover, we 
suggest a possible role of ROS in hESC differen-
tiation; ROS enhances differentiation of hESCs into 
bi-potent mesendoderm that can specify both 
mesoderm and endoderm (Tada et al., 2005) via 
the activation of MAPKs family and/or AKT signal 
transduction by ROS. 
Results
Generation of endogenous ROS in hESCs
BSO which inhibits intracellular glutathione and 
enriches the level of ROS was used for ROS 
induction in hESCs and generated ROS were 
detected by DCF-DA staining. DCF-DA is trapped 
within cells by esterification and converted in its 
fluorescent form by reaction with peroxides 
(Bunting, 2002). Endogenous ROS was generated 
dose-dependently in hESCs and was peaked at 
0.5 mM (Figure 1A) without serious apoptosis 
(Figure 1B). Serious apoptosis was observed at a 
high concentration (1 mM) of BSO (Figure 1B) and 
the ROS level was also decreased slightly (Figure 
1A). We performed apoptosis analysis to deter-
mine the moderate ROS-induced conditions. At the 
high concentration, hESCs had an increased 
number of dead and floating cells from day 2 after 
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Figure 2. Loss of pluripotency in ROS-induced hESCs. Increased ROS abrogates the maintenance of stemness in hESCs. Cells were grown in media 
with or without BSO. Then, we observed the morphology of hESCs through day 5. (A) Phase contrast microscope images represented a compact hESC 
colony at 0.0 mM as a control. Human ESCs exposed to BSO were shown differentiated form. Morphologies of ROS-induced hESCs lost the un-
differentiated shape. Microscopic data represented differentiation of hESCs increasing the concentration of BSO. (B) Diminished expression of hECS 
markers by ROS is shown by a confocal microscope. Cells were grown in 35 mm dishes for 5 days, followed by immunocytochemisty using anti-Tra 1-60 
and anti-Oct 4 antibodies. Downregulation of hESC markers (Oct 4 and Tra-1-60) shown in a dose-dependent manner. The graph was representative 
average of positive cells. *P ＜ 0.05, significantly different from the untreated control. (C) Decreased expression of pluripotency markers in ROS-elevated 
hESCs. Representative RT-PCR data are shown down-regulation of pluripotent markers using cDNA of undifferentiated hESCs and ROS-induced hESCs 
samples for 5 days cultured in a dose-dependent manner of BSO. GAPDH was internal controls.
treatment with BSO. The percentage of apoptotic 
cells at 1 mM had increased 3 or 4-fold (n = 3 for 
each experimental condition; Figure 1B) compared 
with the low concentration groups (0.1-0.5 mM) 
and up to 20-fold on different experiments (data 
not shown). 
Down-regulated expression of pluripotency markers 
in hESCs by ROS
To examine the biological effects of ROS on the 
pluripotency of hESCs, the cells were treated with 
BSO in a dose-dependent manner. Human ESCs 
are characterized by a high ratio of nucleus to 
cytoplasm. Treatment of ROS induced differentia-
tion of hESCs, as characterized by morphologic 
changes and decreased expression of pluripotency 
markers. Phage contrast images showed that at 0 
mM BSO as a control, hESC colonies were 
densely packed cells with smooth outlines and no 
differentiated cells; however, BSO-induced hESC 
differentiation and no compact morphology in a 
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Figure 3. Effect of ROS on hESC or hESC-derived EB differentiation. ROS induces differentiation of hESCs in ROS-elevated condition. Cells were treated 
with BSO in a dose-dependent manner. Treatment of BSO induced differentiation as characterized by RT-PCR at the molecular level. (A) Up-regulation of 
three germ layer genes in hESCs. The genes expression were increased in a dose-dependent of BSO. Particularly, gene expressions of mesoderm and 
endoderm were increased in hESCs. (B) Expression of differentiated markers in EBs. Human ESC-derived EBs was grown in EB medium for 5 days. 
Then EBs was maintained in the absence (control) or presence of 0.2 mM BSO for additional 5 days. The cells expressed represented genes. EBs on at-
tached cultures were mainly increased Nkx2.2, HNF3β, PDX-1, and Sox17 and EBs in suspension cultures promoted gene expression for both meso-
derm (brachyury and Nkx2.5) and endoderm (Nkx2.2 and HNF3β) as compared with controls.
concentration-dependent manner (Figure 2A). 
During differentiation, hESCs flattened and lost 
indigenous hESC morphology. Loss of pluripotency 
was confirmed at the molecular level by immu-
nocytochemisty and RT-PCR analysis. As shown in 
Figure 2B, the hESC markers, Oct 4 and Tra 1-60, 
were strikingly decreased in hESCs growing in 
ROS-induced conditions compared with the control 
group. We observed the down-regulation of the 
pluripotency markers, Sox2, Nanog, hTERT, and 
Oct 4, by RT-PCR (Figure 2C). Our data suggest 
that the transcripts of these pluripotent markers 
were also decreased in hESCs by ROS.   
Up-regulated differentiation in hESCs into the both 
mesodermal and endodermal lineage by ROS
Next, to analyze the function of ROS on differen-
tiation, we investigated the expression of the three 
germ layer markers. The cells were treated with 
BSO in a dose-dependent manner. ROS induced 
the differentiation of hESCs, as determined by 
expression of embryonic lineage markers. The 
differentiated shape of hESCs was shown within 1 
day (data not shown). To establish the expression 
of selected differentiation markers, RT-PCR was 
performed (Figure 3). Differentiation to various em-
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Figure 4. Course of differentiated marker expression after ROS treatment in hESCs. Comparison of marker expressions with hESCs at 1, 3, 5, 7, and 9 
days in the ROS-induced conditions. (A) RT-PCR analysis of gene expression in hESCs grown in medium containing with or without BSO. Total RNA was 
extracted from each hESC sample and subjected to RT-PCR analysis with a set of specific primers. Gene expression of brachyury and HNF3β were 
up-regulated in hESCs grown in ROS-elevated conditions. (B) Expression of lineage specific markers in ROS-induced hESCs is day-dependent. Double 
staining was governed on hESCs cultured during days 3, 6, and 9 in ROS-induced conditions with antibodies against βIII-tubulin, brachyury, and HNF3β. 
The graph was representative average of positive cells. *P ＜ 0.05, significantly different from the untreated control.   
bryonic lineages was confirmed by up-regulation of 
Sox1, Ngn3, and Sox3 (ectoderm), brachyury, 
myogenin, and myogenic factor 6 (MyF6; meso-
derm), and HNF3β, AFP, and Sox17 (endoderm). 
The expressions of mesoderm- or endoderm-re-
lated genes were significantly up-regulated in a 
dose-dependent manner of BSO, rather than 
ectoderm-related genes (Figure 3A). These data 
indicated that ROS promoted hESC differentiation 
into bi-potent mesendoderm cells, even in the 
presence of FGF 2, which is the main factor to 
sustain the undifferentiated state of hESCs. So, we 
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Figure 5. Effects of free radical scavengers on ROS-induced differentiation. Two-day-old hESCs after transfer were incubated with or without 100 μM vi-
tamin C for 4-5 days. Free radical scavenger was presented in the cell culture medium until inspection. Note, that in the presence of free radical scav-
engers, ROS-stimulated differentiation was significantly inhibited, but restored hESC markers (Oct4 and SSEA4). This data point suggested involvement 
of ROS. The cells were counted as positive cells for each marker. The graph was shown as the percentage change in hESCs. *P ＜ 0.05, significantly dif-
ferent from the scavenger-untreated controls.
further investigated the ROS effects in EBs, which 
are differentiated cells corresponding to a precursor. 
Changes of gene expression in EBs by ROS in vitro 
culture 
To test the influence of ROS in EB outgrowth, EBs 
were cultured in EB media (hESC culture medium- 
reduced FGF 2). Human ESCs were detached 
from culture dishes by 2.5 mg/ml of collagenase IV, 
and the aggregates of hESCs were cultured in EB 
media for 5 days. The diagnosis of differentiation in 
EBs differs in accordance with the culture method. 
We then grew the spontaneously differentiated 
EBs by suspension or attached cultivation with (0.2 
mM) or without BSO for additional 5 days. As 
shown in Figure 3B, EBs on attached cultures were 
mainly increased Nkx2.2, HNF3β, PDX-1, and 
Sox17, which is an endoderm lineage in ROS-ele-
vated conditions. Moreover, EBs in suspension 
cultures promoted gene expression for both meso-
derm (brachyury and Nkx2.5) and endoderm 
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Figure 6. The activation of four distinct protein kinase cascades and the change of gene expression by specific inhibitor. (A) Western blots demonstrating 
synchronous phosphor-activation of MAPKs family initiated by endogenous ROS in hESCs. Antibodies recognize phosphorylated residues. Cells were ex-
posed to ROS in time-dependent manners, lysed, electrophoresed on 9% or 12% polyacrylamide gels, and probed with the appropriate phosphor-
ylation-state specific primary antibody. (B) Effects of MAPKs family inhibitors on the expression of hESC marker (Oct4) or lineage-specific markers (olig2, 
braychyury, and HNF3β). The data are presented as relative change of gene expression as compared to the untreated control.
(Nkx2.2 and HNF3β) as compared with controls. 
The present results demonstrated that ROS 
induced differentiation in both undifferentiated 
hESCs and EBs into mesoderrmal and endodermal 
lineages. 
    We also observed the expression of genes in 
accordance with days. The specific genes were 
detected as early as day 1 for mesodermal or 
endodermal lineages in hESCs and reached a 
significant level from days 3-7 (Figure 4A). More-
over, immunocytochemistry analysis showed that 
on day 3, the specific marker-positive cells appeared 
for brachyury or HNF3β, but not βIII-tubulin, and on 
day 6, the maximal expression was shown (n = 3 
for each experimental condition; Figure 4B). There-
fore, we suggest that ROS can commit differen-
tiation of hESCs or EBs to a specific mesen-
doderm lineage.   
Effect of free radical scavenger on induced 
differentiation of hESCs by ROS
We perceived that ROS induced differentiation of 
hESCs into the mesendodermal lineage. Whether 
inhibition of ROS generation can obstruct the 
biological changes in hESCs was assessed, and 
the cells in ROS-induced conditions were 
subjected to a free radical scavenger. To investi-
gate the association of ROS and stimulated 
differentiation, hESCs were incubated with the free 
radical scavenger, 100 μM vitamin C, with 0.2 mM 
BSO. The maximum effect of scavenger was 
shown at 100 μM; however, at 50 μM there was no 
effect for blocking the differentiation of hESCs 
(data not shown), and hESCs had increased cell 
death at a higher concentration (200 μM; data not 
shown). The free radical scavenger was conti-
nuously exposed to hESCs in ROS-induced 
conditions for 4-5 days. The free radical scavenger 
ROS induced differentiation in hESCs     183
influenced the translation of differentiating or 
undifferentiating markers. Treatment of scavenger 
decreased the expression of brachyury and HNF3β 
and increased the expression of the pluripotency 
marker, Oct 4, as well as stage-specific embryonic 
antigen-4 (SSEA 4) in hESCs. As shown in Figure 5, 
the expression of brachyury and HNF3β were 
diminished in hESCs by free radical scavenger. 
Comparably, hESC markers (Oct4 and SSEA4) were 
increased in the presence of free radical scavenger 
(n = 3 for each experimental condition; Figure 5). We 
know that the free radical scavenger inhibited the 
induced-differentiation of hESCs by ROS. 
Activation of MAPKs family by ROS in hESCs
Previous studies have reported that high activity of 
the MEK/ERK signaling pathway promotes diffe-
rentiation of mESCs and hESCs (Burdon et al., 
2002). In the other study, PI3K/AKT and MAPK/ERK 
pathways are decreased upon differentiation of 
hESCs (Armstrong et al., 2006). In this study, we 
observed that ROS promoted the differentiation of 
hESCs into the mesendodemal lineage. To under-
stand the molecular mechanism of the hESC 
differentiation induced by ROS, we focused on the 
MAPKs family as a main target signaling pathway of 
ROS. Whether the MAPKs family is involved in 
hESC differentiation, activation of these signaling 
pathways was examined in a time course. Even 
though at low concentration of BSO (0.2 mM), 
p38MAPK and AKT phosphorylation levels were 
significantly decreased in hESCs culture. JNK and 
ERK phosphorylation levels were increased at early 
time of BSO treatment but not at late time point 
(Figure 6A). These results suggest that activation of 
MAPKs is influenced by BSO and ROS can be key 
regulator on the activation of MAPKs family. 
    To investigate the role of MAPKs family in 
hESCs commitment, we analyzed the effects of 
specific inhibitors in ROS-induced hESCs. 10 μM 
MEK (upstream of ERK) inhibitors, U0126; 1 μM 
JNK inhibitor, SP600125; 1 μM p38MAPK inhibitor, 
SB203580 and 50 μM PI3K/AKT inhibitor, LY294002 
were treated in ROS-induced hESCs for 2 days, 
respectively. ROS-induced brachyury and HNF3 β 
expressions were decreased in hESCs by all used 
inhibitors. On the other hand, ectodermal gene, 
Olig2 expression was increased (Figure 6B). 
These results suggest that ROS can regulate the 
hESC differentiation via MAPKs signaling.
Discussion
In this study, we have described the biological 
effects of ROS on hESC differentiation, particularly 
into mesendodermal lineages. This study is the 
first trial to determine the responses of hESCs in 
ROS-induced conditions. Furthermore, we demon-
strated the down-regulation of pluripotency and 
up-regulation of differentiation into a mesendoder-
mal lineage in hESCs as well as hESC-derived 
EBs. 
    Previous studies have reported that differentiation 
into specific cell types from mESCs may be 
facilitated by ROS (Ateghang et al., 2006; 
Buggisch et al., 2007; Ding et al., 2008; Lange et 
al., 2009). ROS was generated by a growth factor 
related-specific process (Lange et al., 2009) or 
NADPH oxidase (Sauer et al., 1999) in mESC-de-
rived EBs that induced differentiation, especially 
into cardiomyocytes or endothelial cells. These 
studies have shown the significance of ROS 
function in inducing differentiation of mESCs. In 
this study, we first characterized the ROS effect on 
pluripotency of hESCs. For this purpose, we used 
BSO to induce ROS-elevated conditions (Ito et al., 
2006). As a result, loss of pluripotency was 
observed in hESCs by an elevated level of ROS; 
we confirmed the significant down-regulation of 
Oct4, Sox2, Nanog, and Tra-1-60, as well as 
hTERT. We propose that ROS induced decreased 
pluripotency of hESCs, indicating induction of 
differentiation of hESCs. The cells were morpho-
logically differentiated by ROS, even though 
hESCs were grown in ES media containing 4 ng/ml 
of FGF 2. Considering that exogenous FGF 2 has 
been used as an important factor in maintaining 
the undifferentiated state of hESCs (Dvorak et al., 
2005), these results indicated that ROS affected 
hESC pluripotency, overcoming the effects of FGF 
2. 
    A role for ROS in embryogenesis has been 
reported for the past decade. Various studies have 
suggested that ROS play a determining role in 
cellular differentiation (Sohal et al., 1986). In our 
current study it was shown that differentiation of 
hESCs can be accelerated by ROS within 1 day; 
the cells changed their morphology into a 
differentiated form, the expression of both early 
mesoderm- and endoderm-specific markers were 
up-regulated and pluripotency markers were 
down-regulated. Therefore, we suggest that ROS 
is involved in inducing the differentiation of hESCs. 
Maximal effects were achieved at the concen-
tration of BSO of as low as 0.5 mM without 
apoptosis which was observed at days 3-6. We 
also assessed the effects of ROS in hESC-derived 
EBs. The differentiation of EBs differs according to 
the culture method. When cultured by suspension 
or attached cultivation, EBs tended to express the 
184    Exp. Mol. Med. Vol. 42(3), 175-186, 2010
mesoderm or endoderm, respectively. We consi-
dered that ROS act as a signaling molecule and 
that induce the differentiation of hESCs as well as 
EBs into specific cell lineages. Our results 
correspond to previous studies in mESCs (Sauer 
and Wartenberg, 2005; Ateghang et al., 2006; 
Buggisch et al., 2007). Additionally, we observed 
that the free radical scavenger inhibited the 
induced-differentiation of hESCs by ROS, which 
strongly suggests the role of ROS in the triggering 
of hESCs differentiation. 
    In this study, we observed the activation of the 
MAPKs family and AKT signal transduction in 
hESCs by ROS. It has been previously reported 
that ROS production mediates on signaling 
pathway (Thannickal and Fanburg, 2000). In 
ligand-receptor-mediated, intracellular signaling is 
commonly promoted by ROS. ROS acts primarily 
by maintaining phosphorylation of signal molecules 
in intracellular signaling pathways (Allen and 
Tresini, 2000). Exogenously- or endogenously-pro-
duced ROS activate the MAP kinases family such 
as ERK, JNKs and p38MAPK. In our study, hESCs 
as a control group were cultured in media without 
FGF 2 for 2-4 weeks, in order to prevent the 
possible phosphorylation of MAPK family and AKT 
by FGF 2. The phosphorylation of ERK1/2 and 
JNK were elevated in early time point and 
p38MAPK and AKT were down-regulated by ROS 
in hESCs, regardless of the presence of FGF 2. 
We suggest that ROS can regulate the hESC 
differentiation via MAPKs signaling. We used BSO 
to induce ROS generation in hESCs. BSO 
increased the ROS levels at low concentrations 
(0.1-0.5 mM), whereas increased apoptosis 
occurred at a high concentration (1.0 mM). Presu-
mably, a higher concentration of BSO increases 
excessive endogenous ROS causing oxidative 
stress, which is detrimental to hESCs. Therefore, 
the concentrations of between 0.1-0.5 mM were 
used for ROS production. These concentrations of 
ROS have been also employed in another previous 
study that used hematopoietic stem cells (Ito et al., 
2006). Our results may provide a possible new 
comprehension of ROS effects and molecular 
mechanism of ROS-induced signal transductions in 
hESCs. We plan to study the differentiation of 
hESCs into specific cell types by ROS. Also, the 
key downstream effectors of the MAPKs family and 
AKT signaling pathways remain to be further 
studied in hESCs. 
    The limitations of this study are as follows. We 
did not observe the effect of ROS for long-term 
culture in hESCs or EBs. Because hESCs were 
cultured on mitotically-inactivated STO, which are 
best maintained for a week as feeder cells, so 
hESCs increased spontaneous differentiation when 
grown for more than 1 week. Therefore, we 
investigated the effects of ROS in hESCs around 7 
days to eliminate spontaneous differentiation of 
hESCs. In EBs, we showed increasing cell death in 
spite of low concentration of BSO when EBs were 
grown for more 2 weeks in ROS-induced condi-
tions. Because of these technical limitations, we 
performed the experiments for ROS effects in 
hESCs for a short-term culture.
Methods
Human ESC cultures
The human embryonic stem cell lines, SNUhES3 (passage 
27-80) and SNUhES11 (passage 30-80), were used, and 
the undifferentiated hESCs were maintained as described 
in previous report (Oh et al., 2005). In each experiment, 
hESCs were transferred to 35-mm tissue culture dishes; 2 
days thereafter, the cells were grown in the presence of 
buthionin sulfoximine (BSO; Sigma-Aldrich) in a dose-de-
pendent manner. Under these conditions, hESCs were 
removed from the culture dishes mechanically on day 7 
(BSO treatment for 5 days) for measurement of the ROS 
levels. 
ROS induction and inhibition  
Human ESCs were treated with BSO in a dose-dependent 
manner (0.1-1.0 mM) from 2 days after transfer. The media 
containing BSO were changed every 24 h for 5 days. On 
day 5, hESCs were detached by a mechanical method 
from STO feeder cells, and trypsinized by diluted 0.025 
mM trypsin-EDTA to single cells. After washing, the cells 
were incubated with 10 μM 2',7'-dichloroflurescein diace-
tate (DCF-DA; Sigma-Aldrich) for 30 min in a 37oC water 
bath in darkness. The production of ROS was measured 
by a FACSCalibur flow cytometer (Becton, Dickinson and 
Company, Franklin Lakes, NJ, http://www.bd.com) using a 
CellQuest program. In parallel experiments, ROS were 
scavenged by 100 μM vitamin C (Sigma-Aldrich).
    For MAPK or AKT inhibition, U0126 (10 μM, MEK 
inhibitor), SP600125 (1 μM, JNK inhibitor), SB203580 (1 
μM, p38MAPK inhibitor), or LY294002 (50 μM, PI3K/AKT 
inhibitor) were treated for 2 days with BSO.
Measurement of intracellular ROS
DCF-DA is a non-specific probe for ROS to produce 
fluorescent 2'-7'-dichlorofluorescin. The acetate groups of 
the DCF-DA are cleaved in vivo by indigenous esterases, 
and subsequent oxidation by intracellular peroxides 
produces the fluorescent DCF-DA (Thannickal and 
Fanburg, 2000), which can be detected by flow cytometry. 
Human ESCs were mechanically detached from culture 
dishes. Colonies of hESCs were treated with trypsin/EDTA 
to make single cells. Cells were washed with 
Krebs-Ringer-HEPES (KRH) buffer containing 1 mM 
calcium, 0.1 mM glucose, and 0.2% BSA. These cell 
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suspensions were incubated with 10 μM DCF-DA in a 
37oC water bath for 30 min. To prevent degradation of 
DCF-DA from lights, we performed the reaction in the 
darkness.
Immunocytochemistry 
Immunocytochemistry was performed as described in 
previous report (Park et al., 2008). The cells were 
incubated with the following primary antibodies: rabbit 
anti-Oct 4 antibody (1:400; Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA, http://www.scbt.com), mouse anti-Tra-1-60 
(1:400; Chemicon, Temecula, CA, http://www.millipore.com), 
rabbit anti-brachyury (1:200; Santa Cruz Biotechnology, 
Inc.), rabbit anti-HNF3β (1:200; Santa Cruz Biotechnology, 
Inc.), and mouse anti-βIII tubulin (1:200; Santa Cruz 
Biotechnology, Inc.) for 2 h at RT. The cells were washed 
with PBS three times and incubated with an Alexa FluorⓇ 
488 donkey anti-rabbit IgG (1:400) or Alexa FluorⓇ 594 
donkey anti-mouse IgG (1:400; Molecular Probes, Eugene, 
OR, http://www.invitrogen.com) for 40 min at RT. The cells 
were also counterstained with 4',6-diamidino-2-phenyl-
indole (DAPI; Vector Laboratories, Burlingame, CA,  
http://www.vectorlabs.com). Cells were examined using a 
confocal microscope (Nikon, Yokohama, Japan, http:// 
www.nikon.com) equipped with a Radiance 2100 MP 
(Bio-Rad, Hercules, CA, http://www.bio-rad.com) using a 
Laser Sharp 2000 program (Bio-Rad). 
Detection of apoptosis
For detection of apoptosis, we performed Annexin V 
staining by FITC conjugated-Annexin V following the 
manufacturer's method (BD Pharmingen, San Diego, CA, 
http://www.bdbiosciences.com). Briefly, annexin V 
(FITC-labeled, 5 ml), propidium iodide (10 ml), and the 
binding buffer (400 ml) were added to a final volume of 500 
mL, and then analyzed by a FACSCalibur flow cytometer 
(BD Science) within 30 min.
RT-PCR 
Total RNA was extracted using TRIZOL (Invitrogen). Total 
RNA from each sample was used for first-strand cDNA 
synthesis by SuperscriptTM First Strand Synthesis System 
for RT-PCR (Invitrogen), according to the manufacturer's 
instructions. Aliquots of cDNA were used as a template for 
PCR amplification with specific primer sets. The primer set 
is listed in Supplemental data Table S1. Ten μl of PCR 
products were separated on a 2% agarose gel and 
visualized by ethidium bromide staining. The relative 
expression levels of the detected genes from these cells 
were estimated visually by comparing relative band 
intensities with the level of expression of the housekeeping 
gene, GAPDH.
Western blot analysis
For Western blot analysis, hESCs were harvested with 2.5 
mg/ml of collagenase IV (Invitrogen) and washed with 
PBS. The cells were lysed in ice-cold lysis buffer 
containing 150 mM Tris-HCl (pH 7.4), 1% Triton X-100, 25 
mM sodium fluoride (NaF), 80 mM beta-glycerophoshpate, 
25 mM Na3VO4, and 1% phosphatase inhibitor cocktail 
(Sigma-Aldrich). The cell lysates were incubated on ice for 
30 min and centrifuged at 10,000 g for 30 min at 4oC. After 
equalizing the protein concentrations, the total lysates 
were mixed with ×5 sample buffer and boiled for 5 min. All 
samples were subjected to 9% or 12% SDS-PAGE, and 
electrotransferred onto Hybond P membranes (Amersham 
Pharmacia Biotech, Bukinghamshire, UK, http://www. 
apbiotech.com). The membranes were blocked with 3% 
BSA and incubation with primary antibodies were carried 
out at 4oC overnight using rabbit monoclonal antibodies 
directed against ERK1/2 (1:1000; Santa Cruz Biotechnology, 
Inc.), anti-JNK (1:1000), anti-p-JNK (1:1000), anti-p38MAPK 
(1:1000), anti-p-p38MAPK (1:1000), anti-AKT (1:1000), 
and anti-p-AKT (1:1000), which were all from Cell 
Signaling Technology (Boston, MA, http://www.cellsignal. 
com), and mouse monoclonal anti-p-ERK1/2 (1:1000; 
Santa Cruz Biotechnology, Inc.). After washing, the mem-
branes were incubated with the respective HRP-conjuga-
ted secondary antibody for 1 h at room temperature. 
Protein expression was detected by enhanced peroxidase 
detection (EPD; ELPIS BIOTHECH, INC., Taejeon, Korea, 
http://www.elpis-biotech.co.kr) and protein bands were 
visualized by film exposure. GAPDH was used as an 
internal control. 
Statistics
The data are presented as the mean and standard error of 
the mean. Pairwise testing for the difference between 
sample means was done with a two-tailed t-test. The 
general linear model procedure was used to analyze more 
than two independent samples that were further 
sub-grouped by an additional variable factor. To obtain 
information regarding the differences among specific group 
means, Student's t-test was used to perform multiple 
pairwise comparisons. The statistical significance was 
assigned to the 0.05 level. 
Supplemental data
Supplemental Data include a table and can be found with 
this article online at http://e-emm.or.kr/article/article_files/SP- 
42-3-03.pdf.
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